Perioperative conditions affect long-term hypertrophic scar formation

Annals of Plastic Surgery

Volumn 65, Issue 3, 2010, Pages 321-325

  Van Der Veer, Willem M ^a   Ferreira, José A ^a   De Jong, Etty H ^b   Molema, Grietje ^c   Niessen, Frank B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Plastic and Reconstructive Surgery ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiopulmonary bypass; Corticosteroids; Dexamethasone; Disease susceptibility; Hypertrophic scar; Risk factors; Surgery; Wound healing

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEART SURGERY; HUMAN; HYPERTROPHIC SCAR; INTRALESIONAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; NETHERLANDS; PERIOPERATIVE PERIOD; PROSPECTIVE STUDY; STERNUM; TREATMENT OUTCOME;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CICATRIX, HYPERTROPHIC; COHORT STUDIES; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; NETHERLANDS; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; STERNUM; TREATMENT OUTCOME;

EID: 77957987847     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e3181c60f88     Document Type: Article

References (35)

1. Bock O, Schmid-Ott G, Malewski P, et al. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. 2006;297:433-438.
2. van der Veer WM, Bloemen MC, Ulrich MM, et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns. 2009;35:15-29.
3. Bloemen MC, van der Veer WM, Ulrich MM, et al. Prevention and curative management of hypertrophic scar formation. Burns. 2009;35:463-475.
4. Bernabei P, Rigamonti L, Ariotti S, et al. Functional analysis of T lymphocytes infiltrating the dermis and epidermis of post-burn hypertrophic scar tissues. Burns. 1999;25:43-48.
5. Tredget EE, Shankowsky HA, Pannu R, et al. Transforming growth factorbeta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg. 1998;102:1317-1328; discussion 1329-1330. (Pubitemid 28468668)
6. Tredget EE, Yang L, Delehanty M, et al. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res. 2006;26:179-189.
7. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell. 1998;93:487-490.
8. Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon. 2007;5:175-180.
9. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138:1149-1155.
10. Sherris DA, Larrabee WF, Murakami CS. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am. 1995;28:1057-1068.
11. Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-571.
12. Elliot D, Cory-Pearce R, Rees GM. The behaviour of presternal scars in a fair-skinned population. Ann R Coll Surg Engl. 1985;67:238-240.
13. Peacock EE, Madden JW, Trier WC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J. 1970;63:755-760.
14. Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg. 2007;31:468-492; discussion 493-1464
15. Polat A, Nayci A, Polat G, et al. Dexamethasone down-regulates endothelial expression of intercellular adhesion molecule and impairs the healing of bowel anastomoses. Eur J Surg. 2002;168:500-506.
16. Zhang N, Fang Z, Contag PR, et al. Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood. 2004;103:617-626.
17. Oishi Y, Fu ZW, Ohnuki Y, et al. Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases. Br J Dermatol. 2002;147:859-868.
18. Beer HD, Longaker MT, Werner S. Reduced expression of PDGF and PDGF receptors during impaired wound healing. J Invest Dermatol. 1997;109:132-138.
19. Bolkenius U, Hahn D, Gressner AM, et al. Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells. Biochem Biophys Res Commun. 2004;325:1264-1270.
20. Meisler N, Keefer KA, Ehrlich HP, et al. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J Invest Dermatol. 1997;108:285-289.
21. Wicke C, Halliday B, Allen D, et al. Effects of steroids and retinoids on wound healing. Arch Surg. 2000;135:1265-1270.
22. Parrelli JM, Meisler N, Cutroneo KR. Identification of a glucocorticoid response element in the human transforming growth factor beta 1 gene promoter. Int J Biochem Cell Biol. 1998;30:623-627.
23. Shull S, Meisler N, Absher M, et al. Glucocorticoid-induced down regulation of transforming growth factor-beta 1 in adult rat lung fibroblasts. Lung. 1995;173:71-78.
24. Perez JR, Shull S, Gendimenico GJ, et al. Glucocorticoid and retinoid regulation of alpha-2 type I procollagen promoter activity. J Cell Biochem. 1992;50:26-34.
25. Durmus M, Karaaslan E, Ozturk E, et al. The effects of single-dose dexamethasone on wound healing in rats. Anesth Analg. 2003;97:1377-1380.
26. Tsai WC, Tang FT, Wong MK, et al. Inhibition of tendon cell migration by dexamethasone is correlated with reduced alpha-smooth muscle actin gene expression: a potential mechanism of delayed tendon healing. J Orthop Res. 2003;21:265-271.
27. Fransen E, Maessen J, Dentener M, et al. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest. 1998; 113:1290-1295.
28. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21:232-244.
29. Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503.
30. Bisgaard T, Klarskov B, Kehlet H, et al. Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238:651-660.
31. Hoffmann DF, Cook TA, Quatela VC, et al. Steroids and rhinoplasty. A double-blind study. Arch Otolaryngol Head Neck Surg. 1991;117:990 -993; discussion 994.
32. Lundin A, Magnuson A, Axelsson K, et al. The effect of perioperative corticosteroids on the outcome of microscopic lumbar disc surgery. Eur Spine J. 2003;12:625-630.
33. Jetzek-Zader M, Gudowius S, Feyen O, et al. A single intravenous dose of prednisolone induces phosphatidylserine externalization, loss of surface marker expression and a 24-h net increase in human peripheral blood lymphocytes ex vivo. Rheumatol Int. 2007;27:667-673.
34. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of"low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 2003;167:512-520.
35. Duffield JS. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond). 2003;104:27-38.